Replies to post #143698 on Biotech Values

[DewDiligence]

It’s still early, but BMS-936558 is shaping up to be the ideal kind of cancer drug from a business standpoint. However, BMS-936558 will apparently have apparently plenty of competition, which speaks to the issue in #msg-76257542 and #msg-76302922.